• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西家族性高胆固醇血症的分子基础:七个新型低密度脂蛋白受体(LDLR)基因突变的鉴定

Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations.

作者信息

Salazar Luis A, Hirata Mario H, Cavalli Selma A, Nakandakare Edna R, Forti Neusa, Diament Jaime, Giannini Sérgio D, Bertolami Marcelo C, Hirata Rosario D C

机构信息

Faculty of Pharmaceutical Sciences Medical School, University of Sao Paulo, Sao Paulo, SP, Brazil.

出版信息

Hum Mutat. 2002 Apr;19(4):462-3. doi: 10.1002/humu.9032.

DOI:10.1002/humu.9032
PMID:11933210
Abstract

Low-density lipoprotein receptor (LDLR) gene mutations cause familial hypercholesterol-emia (FH), one of the most common single gene disorders. The spectrum of LDLR mutations in Brazil is not known. The aim of this study was the characterization of LDLR mutations in 35 unrelated Brazilian patients with heterozygous FH. The promoter region, the 18 exons and the flanking intron sequences of the LDLR gene were screened by PCR-SSCP analysis and by DNA sequencing. In addition, we have screened the apolipoprotein B gene (APOB) for known mutations (R3500Q and R3531C) that cause Familial defective apo B-100 (FDB) by PCR-RFLP procedure. We found two nonsense (E92X and C371X) and six missense LDLR mutations (R236W, G322S, G352D, A370T, C675W and C677Y), that were previously described in FH patients from other populations. We also found five novel missense [G(-20)R, T476P, V503G, D580H and S652R] and two novel frame shift LDLR mutations (FsR757 and FsS828). Four patients were found to carry two different mutations in the LDLR gene: G352D and A370T (one patient), S652R and C675W (one patient) and T476P and V503G (two patients). APOB mutations were not found. These findings demonstrate that there is a broad spectrum of mutations in the LDLR gene in FH individuals from Brazil.

摘要

低密度脂蛋白受体(LDLR)基因突变会导致家族性高胆固醇血症(FH),这是最常见的单基因疾病之一。巴西LDLR突变的情况尚不清楚。本研究的目的是对35名不相关的巴西杂合子FH患者的LDLR突变进行特征分析。通过PCR-SSCP分析和DNA测序对LDLR基因的启动子区域、18个外显子及其侧翼内含子序列进行筛查。此外,我们还通过PCR-RFLP方法对载脂蛋白B基因(APOB)进行已知突变(R3500Q和R3531C)的筛查,这些突变会导致家族性缺陷载脂蛋白B-100(FDB)。我们发现了两个无义突变(E92X和C371X)和六个错义LDLR突变(R236W、G322S、G352D、A370T、C675W和C677Y),这些突变先前在其他人群的FH患者中已有描述。我们还发现了五个新的错义突变[G(-20)R、T476P、V503G、D580H和S652R]和两个新的移码LDLR突变(FsR757和FsS828)。发现四名患者在LDLR基因中携带两种不同的突变:G352D和A370T(一名患者)、S652R和C675W(一名患者)以及T476P和V503G(两名患者)。未发现APOB突变。这些发现表明,巴西FH个体的LDLR基因存在广泛的突变谱。

相似文献

1
Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations.巴西家族性高胆固醇血症的分子基础:七个新型低密度脂蛋白受体(LDLR)基因突变的鉴定
Hum Mutat. 2002 Apr;19(4):462-3. doi: 10.1002/humu.9032.
2
Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR.西班牙家族性高胆固醇血症的分子特征:低密度脂蛋白受体中39个新突变和77个复发突变的鉴定
Hum Mutat. 2004 Aug;24(2):187. doi: 10.1002/humu.9264.
3
Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.低密度脂蛋白受体基因突变和载脂蛋白B基因R3500Q突变对来自南欧人群的家族性高胆固醇血症患者脂蛋白表型的影响。
Eur J Hum Genet. 2003 Dec;11(12):959-65. doi: 10.1038/sj.ejhg.5201079.
4
Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.加拿大患有家族性高胆固醇血症但非法裔血统的受试者中的低密度脂蛋白受体(LDLR)基因突变。
Hum Mutat. 2001 Oct;18(4):359. doi: 10.1002/humu.1205.
5
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.丹麦家族性高胆固醇血症的分子遗传基础与诊断
Dan Med Bull. 2002 Nov;49(4):318-45.
6
Molecular characterization of familial hypercholesterolemia in German and Greek patients.德国和希腊患者家族性高胆固醇血症的分子特征
Hum Mutat. 2004 Mar;23(3):285-6. doi: 10.1002/humu.9218.
7
[Identification of a novel splice mutation of low density lipoprotein receptor gene in a Chinese family with familial hypercholesterolemia].[中国一个家族性高胆固醇血症家系中低密度脂蛋白受体基因新剪接突变的鉴定]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Feb;21(1):14-8.
8
Mutation analysis in 36 unrelated Spanish subjects with familial hypercholesterolemia: identification of 3 novel mutations in the LDL receptor gene.对36名患有家族性高胆固醇血症的西班牙无关受试者进行的突变分析:低密度脂蛋白受体基因中3个新突变的鉴定。
Hum Mutat. 2000 May;15(5):483-4. doi: 10.1002/(SICI)1098-1004(200005)15:5<483::AID-HUMU19>3.0.CO;2-Q.
9
A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.一名家族性高胆固醇血症的中国纯合子:低密度脂蛋白受体基因中一个新的C263R突变的鉴定。
J Hum Genet. 2001;46(3):152-4. doi: 10.1007/s100380170104.
10
Molecular genetics of familial hypercholesterolemia in Spain: Ten novel LDLR mutations and population analysis.
Hum Mutat. 2001 Nov;18(5):458-9. doi: 10.1002/humu.1218.

引用本文的文献

1
Familial hypercholesterolemia: Current limitations and future breakthroughs.家族性高胆固醇血症:当前的局限性与未来的突破
World J Exp Med. 2024 Dec 20;14(4):99968. doi: 10.5493/wjem.v14.i4.99968.
2
Genetic Spectrum of Familial Hypercholesterolaemia in the Malaysian Community: Identification of Pathogenic Gene Variants Using Targeted Next-Generation Sequencing.马来西亚人群家族性高胆固醇血症的遗传谱:应用靶向下一代测序技术鉴定致病性基因突变。
Int J Mol Sci. 2022 Nov 29;23(23):14971. doi: 10.3390/ijms232314971.
3
Genetic Analysis of Iranian Patients with Familial Hypercholesterolemia.
伊朗家族性高胆固醇血症患者的基因分析。
Iran Biomed J. 2018 Mar;22(2):117-22. doi: 10.22034/ibj.22.2.117. Epub 2017 Jul 23.
4
The panorama of familial hypercholesterolemia in Latin America: a systematic review.拉丁美洲家族性高胆固醇血症全景:一项系统综述。
J Lipid Res. 2016 Dec;57(12):2115-2129. doi: 10.1194/jlr.R072231. Epub 2016 Oct 24.
5
Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.基于下一代测序技术对拉脱维亚人群中低密度脂蛋白胆固醇水平升高的受试者进行家族性高胆固醇血症相关突变的鉴定。
BMC Med Genet. 2015 Sep 28;16:86. doi: 10.1186/s12881-015-0230-x.
6
Impact of 3'UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study.PCSK9和LDLR基因3'非翻译区遗传变异对巴西受试者血脂特征及阿托伐他汀反应的影响:一项初步研究。
Int J Clin Exp Med. 2015 Apr 15;8(4):5978-88. eCollection 2015.
7
A new mouse mutant for the LDL receptor identified using ENU mutagenesis.利用ENU诱变鉴定出一种新的低密度脂蛋白受体小鼠突变体。
J Lipid Res. 2008 Nov;49(11):2452-62. doi: 10.1194/jlr.M800303-JLR200. Epub 2008 Jul 15.